| Dr Quatrisa Irving, OD | |
|
1200 E County Line Rd, Ste 166, Ridgeland, MS 39157-1949 | |
| (601) 957-6078 | |
| (601) 957-6924 |
| Full Name | Dr Quatrisa Irving |
|---|---|
| Gender | Female |
| Speciality | Optometrist |
| Location | 1200 E County Line Rd, Ridgeland, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821274648 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 152W00000X | Optometrist | 836 (Mississippi) | Primary |
| Provider Name | Mississippi Eye Care Associates Of Jackson, Pllc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1366697799 PECOS PAC ID: 3476610122 Enrollment ID: O20090324000450 |
News Archive
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
Clinical research studies are the reason medical care has improved leaps and bounds in the past few decades. Without these carefully-designed tests for new drugs, procedures or devices, treatments for diseases would not progress. These studies should be viewed as opportunities, although some people may view them negatively.
Anika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. ("FAB"), a wholly-owned subsidiary of privately held Italian pharmaceutical company, Fidia Farmaceutici S.p.A. FAB provides hyaluronic acid-based ("HA") products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.
The European R&D project BrainAble, led by Barcelona Digital, has just successfully ended by developing a prototype that allows patients with severe functional disability to be more active and independent.
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Quatrisa Irving, OD 1200 E County Line Rd, Ste 166, Ridgeland, MS 39157-1949 Ph: (601) 957-6078 | Dr Quatrisa Irving, OD 1200 E County Line Rd, Ste 166, Ridgeland, MS 39157-1949 Ph: (601) 957-6078 |
News Archive
The drive toward containing health care costs could have the unintended consequence of reducing physician productivity, impairing quality and perhaps even increasing costs, two Beth Israel Deaconess Medical Center physicians suggest in a New England Journal of Medicine "Perspective."
Clinical research studies are the reason medical care has improved leaps and bounds in the past few decades. Without these carefully-designed tests for new drugs, procedures or devices, treatments for diseases would not progress. These studies should be viewed as opportunities, although some people may view them negatively.
Anika Therapeutics, Inc. today announced that it has acquired Fidia Advanced Biopolymers, s.r.l. ("FAB"), a wholly-owned subsidiary of privately held Italian pharmaceutical company, Fidia Farmaceutici S.p.A. FAB provides hyaluronic acid-based ("HA") products in several therapeutic areas including for the regeneration of connective and structural tissues damaged by injuries, aging or degenerative diseases.
The European R&D project BrainAble, led by Barcelona Digital, has just successfully ended by developing a prototype that allows patients with severe functional disability to be more active and independent.
Androgen deprivation therapy (ADT) is a common treatment option for patients with advanced stage prostate cancer. But nearly 80 percent of patients who receive ADT report experiencing hot flashes during and after treatment. Moffitt Cancer Center researchers are working to determine what genetic factors and other characteristics might make prostate cancer patients more likely to experience hot flashes during and after therapy.
› Verified 4 days ago
Rogers Family Eye Care, Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1000 Highland Colony Pkwy Ste 9007, Ridgeland, MS 39157 Phone: 601-957-6078 Fax: 601-957-6924 | |
Dr. Jennifer Hermetz York, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 301 Northlake Ave Ste 101, Ridgeland, MS 39157 Phone: 601-707-5255 Fax: 601-707-5255 | |
Irving Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1200 E County Line Rd, Ste 166, Ridgeland, MS 39157 Phone: 601-957-6078 Fax: 601-957-6924 | |
Dr. Adam Crawford, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 301 Northlake Ave, Suite 101, Ridgeland, MS 39157 Phone: 601-707-5255 | |
Crawford Eye Care Optometrist Medicare: Medicare Enrolled Practice Location: 301 Northlake Ave, Ste 101, Ridgeland, MS 39157 Phone: 601-707-5255 | |
Total Icare Ms Llc Optometrist Medicare: Medicare Enrolled Practice Location: 1200 E County Line Rd, Ste 164, Ridgeland, MS 39157 Phone: 769-208-8930 Fax: 769-208-8831 | |
Dr. Brittany Nicole Rogers, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1200 E County Line Rd Ste 166, Ridgeland, MS 39157 Phone: 601-957-6078 Fax: 601-957-6924 |